featured
IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma
Gastroenterology 2022 Mar 01;[EPub Ahead of Print], V Somani, D Zhang, PB Dodhiawala, VE Lander, X Liu, LI Kang, HP Chen, BL Knolhoff, L Li, PM Grierson, MB Ruzinova, DG DeNardo, KH LimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.